GCM GROSVENOR HOLDINGS, LLC Fate Therapeutics, Inc. Transaction History

GCM GROSVENOR HOLDINGS, LLC portfolio value:

$23.24M
portfolio value

GCM GROSVENOR HOLDINGS, LLC quarter portfolio value change:

-9.56%
quarter

Fate Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -2.45M $22.41 1.03M
Q2 2022 share Increase 0.00% 1.03M shares 25.70M $24.78 1.03M